<DOC>
	<DOCNO>NCT01625611</DOCNO>
	<brief_summary>The primary purpose study increase knowledge receptor function brain people heavy drinker take naltrexone ( NTX ) , medication approve treatment alcohol dependence . Receptors special molecule brain molecule ( neurotransmitter ) attach normal every-day working brain . Drugs bind receptor molecule well . Recent evidence suggest kappa opioid receptor ( KOR 's ) may play important role alcohol drink behavior . This study try determine naltrexone 's ability attach receptor related effectiveness . We use PET ( positron emission tomography ) study . PET type image device find nuclear medicine . It use track presence inject radioactive material body .</brief_summary>
	<brief_title>Kappa-PET Imaging Naltrexone Alcohol Drinking Behaviors</brief_title>
	<detailed_description />
	<mesh_term>Alcohol Drinking</mesh_term>
	<mesh_term>Drinking Behavior</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Ages 2150 Able read English 6th grade level high complete study evaluation Regular alcohol drinker Individuals seek alcohol treatment Medical condition would contraindicate use study medication Regular use substance</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Alcohol</keyword>
	<keyword>Drinking</keyword>
	<keyword>Drinkers</keyword>
	<keyword>Alcohol Drinking</keyword>
	<keyword>Naltrexone</keyword>
	<keyword>Alcohol Dependence</keyword>
	<keyword>Alcohol Abuse</keyword>
	<keyword>Alcohol-Related Disorders</keyword>
	<keyword>Ethanol</keyword>
	<keyword>Alcoholism</keyword>
</DOC>